Biogen Revamps its Outlook by Licensing Next Generation Gene Therapies
By Jasmine Kalsi
Pharma Deals Review: Vol 2016 Issue 6 (Table of Contents)
Published: 15 Jun-2016
DOI: 10.3833/pdr.v2016.i6.2167 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
In two separate deals to strengthen its long-term prospects in ophthalmology and central nervous system therapeutic areas, Biogen has entered into research alliances with the University of Pennsylvania (UPenn) and its spinoff Regenxbio...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS